Literature DB >> 22054735

Systemic mastocytosis.

Tracy I George1, Hans-Peter Horny.   

Abstract

An unusual disease, mastocytosis challenges the pathologist with a variety of morphologic appearances and heterogeneous clinical presentations ranging from skin manifestations (pruritus, urticaria, dermatographism) to systemic signs and symptoms indicative of mast cell mediator release, including flushing, hypotension, headache, and anaphylaxis among others. In this article, we focus on recognizing the cytology, histopathology, clinical features, and prognostic implications of systemic mastocytosis, a clonal and neoplastic mast cell proliferation infiltrating extracutaneous organ(s) with or without skin involvement. Diagnostic pitfalls are reviewed with ancillary studies to help unmask the mast cell and exclude morphologic mimics. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054735     DOI: 10.1016/j.hoc.2011.09.012

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

1.  Impaired function of bone marrow stromal cells in systemic mastocytosis.

Authors:  Krisztian Nemeth; Todd M Wilson; Jiaqiang J Ren; Marianna Sabatino; David M Stroncek; Miklos Krepuska; Yun Bai; Pamela G Robey; Dean D Metcalfe; Eva Mezey
Journal:  Stem Cell Res       Date:  2015-05-08       Impact factor: 2.020

Review 2.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

3.  Simultaneous presentation of JAK2 V617F mutation-related essential thrombocythemia and B-cell chronic lymphocytic leukemia.

Authors:  Guido D'Angelo; Anna Maria Hotz; Fabrizio Ciambelli; Sergio Pauli
Journal:  Blood Res       Date:  2014-06-25

Review 4.  Targeted Treatment Options in Mastocytosis.

Authors:  Mélanie Vaes; Fleur Samantha Benghiat; Olivier Hermine
Journal:  Front Med (Lausanne)       Date:  2017-07-20

Review 5.  Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Ivan Alvarez-Twose; Knut Brockow; Olivier Hermine; Marek Niedoszytko; Juliana Schwaab; Jonathan J Lyons; Melody C Carter; Hanneke Oude Elberink; Joseph H Butterfield; Tracy I George; Georg Greiner; Celalettin Ustun; Patrizia Bonadonna; Karl Sotlar; Gunnar Nilsson; Mohamad Jawhar; Frank Siebenhaar; Sigurd Broesby-Olsen; Selim Yavuz; Roberta Zanotti; Magdalena Lange; Boguslaw Nedoszytko; Gregor Hoermann; Mariana Castells; Deepti H Radia; Javier I Muñoz-Gonzalez; Wolfgang R Sperr; Massimo Triggiani; Hanneke C Kluin-Nelemans; Stephen J Galli; Lawrence B Schwartz; Andreas Reiter; Alberto Orfao; Jason Gotlib; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Hemasphere       Date:  2021-10-13

6.  Current concepts on diagnosis and treatment of mastocytosis.

Authors:  D Magliacane; R Parente; M Triggiani
Journal:  Transl Med UniSa       Date:  2014-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.